Should Managed Care Organizations Pay for Nicotine Replacement Therapy?

As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.

Clinicians from University of Chicago Medicine, Northwestern Medicine, and Loyola Medicine said bispecific antibodies for early-relapse myeloma can be given safely outside the hospital, but staffing, after-hours triage, and community confidence have yet to catch up.

A 35-year Danish registry study found MACE declined in every income quartile, but the lowest earners kept higher rates than top earners throughout.

Low-dose CT (LDCT) screening for individuals with a family history of lung cancer was cost-effective using Taiwan-based parameters; future work should incorporate real-world program data and subgroup analyses.

Dallas population health roundtable exposes prior authorization hurdles, ICD coding gaps, and copay barriers delaying care coordination.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.

ASN Kidney Week 2026 experts discussed GLP-1 RAs alongside lifestyle care, global access, and bariatric surgery for obesity in chronic kidney disease.